comparemela.com
Home
Live Updates
Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights : comparemela.com
Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
- On Track to Report Initial Data from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD During the Second Half of 2023 - WALTHAM, Mass., Aug. 03, 2023 --...
Related Keywords
,
Amy Reilly ,
Stacy Nartker ,
Joshua Brumm ,
Nasdaq ,
Twitter ,
Facebook ,
Linkedin ,
Exchange Commission ,
European Medicines Agency ,
Dyne Therapeutics Inc ,
American Society Of Gene Cell Therapy ,
Report Initial Data ,
Second Half ,
American Society ,
Cell Therapy ,
Annual Meeting ,
Private Securities Litigation Reform Act ,
Consolidated Statement ,
Months Ended June ,
Consolidated Balance Sheet Data ,
Markets ,
comparemela.com © 2020. All Rights Reserved.